Acquisition synergies Kalderos was acquired by Model N in June 2026 to expand 340B capabilities and gross-to-net revenue management, presenting an opportunity to position complementary monetization and compliance solutions to the combined entity.

Independent platform strength Position Kalderos as a leading independent platform for drug discount management and revenue integrity within healthcare, targeting providers, manufacturers, payers, and government agencies seeking transparency and cost containment.

Leadership expansion Recent and upcoming executive appointments in product, operations, strategy, and engineering indicate a focus on scale, productization, and market leadership—funding and alignment for enterprise sales cycles.

Healthcare data maturity With a tech stack spanning Snowflake, SQL, Google Cloud, TensorFlow, and data governance tools, Kalderos targets organizations with advanced data infrastructure needs for discount management and revenue integrity analytics.

Revenue and growth Reported revenue in the mid-to-high tens of millions and a total funding of modest hundred millions signal a company poised for expanded deployments, making upsell opportunities around governance, analytics, and interoperability compelling for existing customers.